NPPB and acute coronary syndrome: Two previous sub-analyses based on multicenter trials in acute coronary syndromes revealed that MCP-1 can be identified as an independent risk stratification biomarker in addition to C-reactive protein (CRP) and brain natriuretic peptide (BNP) [15,16].